Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
Yanan Lv, Xiaona Gao, Yan Luo, et al.
The Journal of Nutritional Biochemistry (2019) Vol. 71, pp. 110-121
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
Lili Yu, Wei Hong, Shen Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 79
Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
Zarina Mushtaq, Nabeelah Bibi Sadeer, Muzzamal Hussain, et al.
International Journal of Food Properties (2023) Vol. 26, Iss. 1, pp. 1914-1939
Open Access | Times Cited: 45
Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
Viviana Sandoval, Hèctor Sanz‐Lamora, Giselle Arias, et al.
Nutrients (2020) Vol. 12, Iss. 8, pp. 2393-2393
Open Access | Times Cited: 80
Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2
Weiwei Zhu, Namood-e Sahar, Hafiz Muhammad Ahmad Javaid, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3306-3306
Open Access | Times Cited: 69
Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
Yongmei Li, Zean Zhao, Jian Luo, et al.
Phytomedicine (2021) Vol. 87, pp. 153585-153585
Closed Access | Times Cited: 61
Apigenin Alleviates Obesity-Associated Metabolic Syndrome by Regulating the Composition of the Gut Microbiome
Yuan Qiao, Zhichun Zhang, Yuanyuan Zhai, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 45
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
Panli Tan, Jin Li, Xiang Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
Chenhao Yao, Shu Dai, Cheng Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115464-115464
Open Access | Times Cited: 38
Apigenin Alleviated High-Fat-Diet-Induced Hepatic Pyroptosis by Mitophagy-ROS-CTSB-NLRP3 Pathway in Mice and AML12 Cells
Zhuoqun Meng, Min Gao, Chunyun Wang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 18, pp. 7032-7045
Closed Access | Times Cited: 30
Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice
Wenjing Tao, Wanjing Sun, Lujie Liu, et al.
Marine Drugs (2019) Vol. 17, Iss. 11, pp. 645-645
Open Access | Times Cited: 70
Beneficial impacts of fermented celery (Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice
Dong Zhao, Jinhu Cao, Huiqin Jin, et al.
Food & Function (2021) Vol. 12, Iss. 19, pp. 9151-9164
Closed Access | Times Cited: 46
Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota
Ruiting Han, Huihui Qiu, Jing Zhong, et al.
Phytomedicine (2021) Vol. 85, pp. 153544-153544
Closed Access | Times Cited: 43
Purine metabolism in the development of osteoporosis
Keda Yang, Jie Li, Lin Tao
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113784-113784
Open Access | Times Cited: 29
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
Longshan Ji, Qian Li, Yong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3529-3547
Open Access | Times Cited: 27
Qualitative and quantitative analysis of chemical components in Qianggan capsule by UHPLC-Q-TOF-MS/MS and LC-sMRM
Xiaoliang Zhu, Mengmeng Lin, Yuqian Chi, et al.
Journal of Chromatography A (2024) Vol. 1728, pp. 465020-465020
Closed Access | Times Cited: 5
Prophylactic effects of apigenin against hyperglycemia-associated amnesia via activation of the Nrf2/ARE pathway in zebrafish
B. Haridevamuthu, S.P. Ramya Ranjan Nayak, Raghul Murugan, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176680-176680
Closed Access | Times Cited: 5
Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real‐time two‐dimensional shear wave elastography: A randomized clinical trial
Davood Soleimani, Mitra Rezaie, Farnood Rajabzadeh, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1669-1679
Closed Access | Times Cited: 48
Targeting the NLRP3 Inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders
Wei‐Lun Hung, Chi‐Tang Ho, Min‐Hsiung Pan
Molecular Nutrition & Food Research (2019) Vol. 64, Iss. 4
Closed Access | Times Cited: 44
The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice
Geng‐Ruei Chang, Weili Lin, Tzu-Chun Lin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11383-11383
Open Access | Times Cited: 39
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4459-4459
Open Access | Times Cited: 38
Active Flavonoids From Lagotis brachystachya Attenuate Monosodium Urate-Induced Gouty Arthritis via Inhibiting TLR4/MyD88/NF-κB Pathway and NLRP3 Expression
Xiang Ying Ouyang, Na-Zhi Li, Min-Xia Guo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
Zheng‐Rong Lu, Lu Liu, Shunxin Zhao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosis
Bolin Zhao, Kai Liu, Xing Liu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3122-3145
Closed Access | Times Cited: 4
Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge
Wenyi Gu, Jiajing Zhao, Yu Xu
Frontiers in Immunology (2025) Vol. 16
Open Access
Pseudonatural Flavonols as Novel Copper Ionophores for NAFLD Intervention via Synergistic Copper Delivery and Flavonoid Activity
Jun Jiang, Gang Chen, Weiqin Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Page 1 - Next Page

Scroll to top